Related Articles
miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN
MicroRNA‑425 upregulation indicates better prognosis in younger acute myeloid leukemia patients undergoing chemotherapy
Oncogenic miR‑425‑5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
Downregulation of microRNA‑425‑5p suppresses cervical cancer tumorigenesis by targeting AIFM1